Search

everythinglearnresearchcommunity

for

Search:↓

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

ADM scaffolds help skin heal by promoting a healing-type immune response.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Upadacitinib may effectively treat alopecia areata without side effects.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Targeting Vδ1+T-cells may help treat alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The combination of Arginine Silicate Inositol Complex and a new form of Biotin improved hair and nail growth in rats.

The treatment might help COVID-19 related hair loss, but more research is needed.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

PRP treatment may help with alopecia areata, especially in newer cases.

Oral ulcers are common in SLE patients and often link to other symptoms.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Some drugs used to treat immune conditions may cause different types of hair loss.